Our work
Our current research aims include:
- New nanoparticles for surgical oncology to enable improved intraoperative imaging and targeted therapy.
- Investigation of ablative techniques for surgery (e.g., ultrasound, near-IR irradiation, cryotherapy) and their combination with chemotherapy as adjuvants to surgery.
- Developing tumouroid 3D in vitro cultures of cancer, which mimic the composition and architecture of solid tumours as platforms for testing therapeutics and stratified medicine.
- Clinical trials in surgical oncology and renal cancer ablation and diagnostics.
- Treatment of infections using nanoparticles with antimicrobial properties.
Latest feature

Using 3D constructs to test the efficacy of clinical drugs
We recently optimised the manufacture of 3D tumouroid constructs using cells from patients with renal cancers, and then used these 3D constructs to test the efficacy of clinical drugs.
Our facilities
- 3D model fabrication and culture of primary cells for cancer
- Nanoparticle manufacture
- Reactive oxygen species detection using time-resolved spectroscopy
- High power laser irradiation
- Ultrasound delivery
- Thermal imaging
- NIR imaging
The Centre for Nanomedicine and Surgical Theranostics (CNS)
Principal Investigators from laboratory and surgical disciplines work alongside postdoctoral, graduate researchers and students. To foster our interdisciplinary approach, we have strong links with other UCL departments, including Chemistry, the School of Pharmacy and Engineering.

Professor of Photochemistry and Photobiology (Head)

Professor of Advanced Therapeutics (Deputy Head)

Professor of Cancer Nanotechnology

Professor of Urology

Associate Professor

Professor of Urology

Associate Lecturer

Senior Clinical Research Fellow

Associate Professor

Associate Professor

Professor of Urology

Honorary Lecturer

Consultant

Senior Research Fellow

Dr Hazel Welch
Senior Teaching Fellow

Honorary Research Associate
Honorary staff

Senior Research Fellow

Honorary Professor in Molecular and Computational Pathology
Funding / Partnerships
Current research funding is drawn from the EPSRC, MRC, Innovate UK, British Council, NIHR (National Institute for Health Research), the Royal Society UK, and charitable sources.
We also work closely with industrial partners. An example of this is nanoparticle testing in experimental cancer models.
Select publications
- Neves JB, Warren H, Santiapillai J, Rode N, Cullen D, Pavlou M, Walkden M, Patki P, Barod R, Mumtaz F ... Gurusamy K, Emberton M, Bex A, Tran MGB (2023). Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial Nephrectomy. Eur Urol. 2023 S0302-2838(23)03012-9.
- Banerjee SM, Acedo P, El Sheikh S, Harati R, Meecham A, Williams NR, Gerard G, Keshtgar MRS, MacRobert AJ, Hamoudi R (2023). Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer. Front Immunol. 2023 14:1188087.
- Hadi MM, Farrell S, Nesbitt H, ... MacRobert AJ, McHale JP, Nomikou N. et al. (2022). Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol.
- Eddama, M.M.R., Gurung, R., Fragkos, K., Lorgelly, P., Cohen, R., Loizidou, M., & Clapp, L. (2022). The role of microvesicles as biomarkers in the screening of colorectal neoplasm. Cancer Medicine.
- Nyga A., Stamati K., Hamoudi R., Tran M.G.B., Emberton M., Loizidou M., Cheema U., et al. Renal tumouroids: challenges of manufacturing 3D cultures from patient derived primary cells. J. Cell Commun. Signal. 2022.
- Hadi M.M., Sciscione F., Emberton M., MacRobert A., McHale A.P., Nomikou N., et al. Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer. J.Control Release. 2021 Jan 10;329:76-86.
- Stamati K., Neves J.B., Tran M.G., Emberton M, Cheema U, Loizidou M.J., et al. The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroids. Tissue Eng. 2020 11:2041731420920597
- Hwang G.B., Huang H., Wu G., Shin J., Kafizas A., MacRobert A.J., et al. Photobactericidal activity activated by thiolated gold nanoclusters at low flux levels of white light. Nature Com. 2020 11(1):1207.
- Banerjee S.M., El-Sheikh S., Malhotra A., Mosse C.A., MacRobert A.J., Hamoudi R., et al. Photodynamic Therapy in Primary Breast Cancer. J Clin. Med. 2020 10;9(2):483.
- Gulamhusein A., Silva P., Cullen D., Tran M., Mumtaz F., Bex A., et al. Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy. BJU Int. 2020.
- Owusu EGA, MacRobert AJ, Naasani I, Parkin IP, Allan E, Yaghini E. Photoactivable polymers embedded with cadmium-free quantum dots and crystal violet: Efficient Bactericidal Activity against Clinical Strains of Antibiotic-Resistant Bacteria. ACS Appl. Mater. Interfaces. 2019 11(13):12367-12378.
- Azimi T, Loizidou M, Dwek MV. Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin. Sci Rep. 2020 21;10(1):12020.
- Neves JB, Cullen D, Grant L, Gurusamy K, Emberton M, Bex A, Tran MGB., et al. Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses. BMJ Open. 2019 11;9(6):e030965.
Related courses

Nanotechnology and Regenerative Medicine MSc
This renowned cross-disciplinary master's programme gives you a robust scientific understanding in the fields of nanotechnology and regenerative medicine.

Burns, Plastic and Reconstructive Surgery MSc
Gain core knowledge and understanding of the latest plastic and reconstructive surgical techniques on this highly innovative MSc.

Intercalated iBSc Surgical Sciences
The Surgical Sciences iBSc introduces surgical skills, surgical practice and research methodology to medical trainees, in a different way to the standard undergraduate curriculum.
Related themes

Breast Research
The Oncoplastic Breast Research Collaborative aims to reduce breast cancer morbidity and mortality by promoting basic, translational and clinical research within UCL & Royal Free Hospital communities.

Responsive Oncotherapeutics
We focus on developing translational drug delivery approaches based on formulations/carriers that are responsive to energy forms (electromagnetics, ultrasound), plus the cancerous microenvironment.

Tumouroids
We have developed Tumouroids, three-dimensional cell cultures which resemble tumour tissues. These are used to investigate the efficacy of anti-cancer agents and for personalised medicine.